KIF4A and osteosarcoma: Similar studies have shown that exosomal miR‐195 inhibited osteosarcoma cell proliferation and antiapoptosis in vitro, inhibited tumor growth in vivo, and reduced tolerance to chemotherapeutic drugs by targeting KIF4A.36